INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![korio_rtsm__site_user_experience]( "Korio RTSM Platform: Site User Experience")
Korio RTSM Platform: Site User ExperienceWith minimal navigation, users of this platform can view a participant list, demographics, and status indicators — taking key actions like screening or randomizing without leaving the main grid.
-
![IQVIA]( "The Next Frontier In Early Phase Oncology Trials")
The Next Frontier In Early Phase Oncology TrialsThis session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.
-
![Senior patient gazing out window in hospital room (high res)]( "Mastering Precision Oncology Start-Up: Reducing Screening Delays")
Mastering Precision Oncology Start-Up: Reducing Screening DelaysBiomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
![altasciences manufacturing supply thumb]( "Successful Manufacturing Of Clinical Trial Supply")
Successful Manufacturing Of Clinical Trial SupplyFormulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.
-
The Ten Commandments Of Vendor Selection7/1/2025
Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.
-
Key Strategies For Clinical Development In Rare Cancers2/11/2025
Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.
-
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk2/24/2026
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
CRO Uses CRIO eSource To Double Monitoring Productivity1/31/2025
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
-
Driving Greater Efficiency Through Modular Trial Design6/27/2025
As clinical trials grow more complex and patient-centric, traditional site-based models are proving insufficient and prompting the rise of modular, technology-enabled delivery strategies.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1390380585 business, meeting, data, research, office]( "Empower Your Research Sites With A Full-Service Marketing Solution")
Built for Sites, Not Just Sponsors
Too many recruitment vendors focus solely on the sponsor’s bottom line, leaving sites stuck managing clunky spreadsheets, manual tracking, and outreach tasks without the infrastructure to scale.
-
![GettyImages-547418608-lab-team-collaboration-planning]( "An Introductory Guide To Clinical EU Qualified Person (QP) Services")
PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
-
![Gene therapy iStock-1177162185]( "Cell And Gene Therapies")
Accelerate your cell or gene therapeutic to market with tailored clinical and regulatory strategies and expert insights.
-
![iqvia-globe]( "IQVIA Investigator Site Portal")
IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) offers sponsors, CROs, and sites the ability to manage trials easily and efficiently, from beginning to end, by enabling users to communicate effortlessly with sites, design and execute goals, and provide reporting, trial metrics, and much more.
-
![logistics-discovery-transport-travel-GettyImages-1287428874]( "Safe-To-Site Initiative")
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
